Appia Bio
Appia Bio
appiabio.com

Locations

Los Angeles, CA, USA

industry

Biotechnology · DeepTech · Health

Size

11-50 employees

Stage

Series A

founded in

2020

Appia Bio is a biotechnology company that focuses on the research and development of off-the-shelf allogeneic cell therapies. It works on discovering and developing engineered allogeneic cell therapies across a broad array of indications with a scalable technology platform that increases access for patients. With its ACUA (Appia Cells Utilized for Allogeneic) technology platform, Appia Bio leverages the biology of lymphocyte development with chimeric antigen receptor (CAR) and T-cell receptor (TCR) gene engineering to generate CAR-engineered invariant natural killer T (CAR-iNKT) cell subtypes from hematopoietic stem cells (HSCs).

Something looks off?
Open jobs at Appia Bio
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.